New Medication Approved in March 2025 for PWS! VYKAT XR

We are so excited to see what this new medication will do to help our loved ones and families! Thanks to Soleno Theraputics and all those with PWSA/USA who spent countless hours helping to get this approved. It gives us to much hope!

“Today marks a historic day for the PWS community. The FDA’s approval of VYKAT XR represents a monumental step forward in addressing the longstanding unmet needs of individuals living with PWS and their families,” -Stacy Ward, Chief Executive Officer of the Prader-Willi Syndrome Association | USA.